Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
Access all of the press releases and statements related to the work of the Vaccine Alliance
4 February 2013
GAVI funds vaccines to protect girls against cervical cancer
30 January 2013
Simon Lamb appointed head of GAVI Internal Audit
25 January 2013
GAVI Alliance significantly expands private sector involvement in saving lives
20 January 2013
GAVI applauds exclusion of vaccines containing thiomersal as preservatives from mercury treaty
15 January 2013
Burundi introduces second dose of measles vaccine
10 January 2013
GAVI recognised for effectiveness and focus on results
20 December 2012
Seth Berkley on health in the post-2015 development agenda
6 December 2012
GAVI awards countries and advocates for accelerating access to life-saving vaccines
GAVI welcomes Germany’s continued support
More than 30 million girls to be immunised with HPV vaccines by 2020 with GAVI support
5 December 2012
Immunisation protecting 370 million additional children through successful global partnership
3 December 2012
100 millionth person receives lifesaving meningitis vaccine